Jpmorgan Chase & CO Isoray, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 26, 2024
BUY
N/A
2,581,128 New
2,581,128 $1.78 Million
Q1 2024

May 10, 2024
BUY
N/A
2,580,646 Added 535403.75%
2,581,128 $1.78 Million
Q4 2023

Dec 26, 2024
BUY
N/A
482 New
482 $0
Q4 2023

Feb 12, 2024
BUY
N/A
152 Added 46.06%
482 $0
Q3 2023

Nov 14, 2023
BUY
N/A
330 New
330 $0

Others Institutions Holding ISR

# of Institutions
2
Shares Held
145K
Call Options Held
0
Put Options Held
0
View Full List

About Isoray, Inc.

ISR Quotes by TradingView
  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email